Culver City, CA, United States of America

Sebastien Lemire

This inventor holds 1 USPTO granted patent. Top assignee: Armata Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sebastien Lemire. Retrieved from https://idiyas.com/inventor/sebastien-lemire-m6y1zqs9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sebastien Lemire

Introduction

Sebastien Lemire is an accomplished inventor based in Culver City, CA. He has made significant contributions to the field of bacteriophage research, particularly in the development of compositions for treating bacterial infections. His innovative work has the potential to revolutionize how we approach bacterial diseases.

Latest Patents

Sebastien Lemire holds a patent for "Bacteriophage compositions for treating infection." This patent relates to bacteriophages and compositions capable of infecting and killing bacteria, providing a novel approach to treating bacterial infections.

Career Highlights

Lemire is currently associated with Armata Pharmaceuticals, Inc., where he continues to advance his research in bacteriophage technology. His work at the company focuses on developing effective treatments for bacterial infections, showcasing his commitment to improving public health.

Collaborations

Sebastien collaborates with talented professionals in his field, including Stacey Lynn Kolar and Brian C. Varnum. These partnerships enhance the research and development efforts at Armata Pharmaceuticals, Inc.

Conclusion

Sebastien Lemire's contributions to bacteriophage research and his innovative patent highlight his role as a leading inventor in the field. His work promises to make a significant impact on the treatment of bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…